These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38171595)

  • 1. Pridopidine subtly ameliorates motor skills in a mouse model for vanishing white matter.
    Oudejans E; Witkamp D; Hu-A-Ng GV; Hoogterp L; van Rooijen-van Leeuwen G; Kruijff I; Schonewille P; Lalaoui El Mouttalibi Z; Bartelink I; van der Knaap MS; Abbink TE
    Life Sci Alliance; 2024 Mar; 7(3):. PubMed ID: 38171595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guanabenz ameliorates disease in vanishing white matter mice in contrast to sephin1.
    Witkamp D; Oudejans E; Hu-A-Ng GV; Hoogterp L; Krzywańska AM; Žnidaršič M; Marinus K; de Veij Mestdagh CF; Bartelink I; Bugiani M; van der Knaap MS; Abbink TEM
    Ann Clin Transl Neurol; 2022 Aug; 9(8):1147-1162. PubMed ID: 35778832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isocaloric low protein diet in a mouse model for vanishing white matter does not impact ISR deregulation in brain, but reveals ISR deregulation in liver.
    Wisse LE; Visser D; Ter Braak TJ; Bakkali A; Struys EA; Morrison CD; van der Knaap MS; Abbink TEM
    Nutr Neurosci; 2022 Jun; 25(6):1219-1230. PubMed ID: 33236691
    [No Abstract]   [Full Text] [Related]  

  • 4. Vanishing white matter: deregulated integrated stress response as therapy target.
    Abbink TEM; Wisse LE; Jaku E; Thiecke MJ; Voltolini-González D; Fritsen H; Bobeldijk S; Ter Braak TJ; Polder E; Postma NL; Bugiani M; Struijs EA; Verheijen M; Straat N; van der Sluis S; Thomas AAM; Molenaar D; van der Knaap MS
    Ann Clin Transl Neurol; 2019 Aug; 6(8):1407-1422. PubMed ID: 31402619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing white matter.
    van der Knaap MS; Bugiani M; Abbink TEM
    Handb Clin Neurol; 2024; 204():77-94. PubMed ID: 39322396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium: effects in animal models of vanishing white matter are not promising.
    Witkamp D; Oudejans E; Hoogterp L; Hu-A-Ng GV; Glaittli KA; Stevenson TJ; Huijsmans M; Abbink TEM; van der Knaap MS; Bonkowsky JL
    Front Neurosci; 2024; 18():1275744. PubMed ID: 38352041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytes are central in the pathomechanisms of vanishing white matter.
    Dooves S; Bugiani M; Postma NL; Polder E; Land N; Horan ST; van Deijk AL; van de Kreeke A; Jacobs G; Vuong C; Klooster J; Kamermans M; Wortel J; Loos M; Wisse LE; Scheper GC; Abbink TE; Heine VM; van der Knaap MS
    J Clin Invest; 2016 Apr; 126(4):1512-24. PubMed ID: 26974157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. eIF2B activator prevents neurological defects caused by a chronic integrated stress response.
    Wong YL; LeBon L; Basso AM; Kohlhaas KL; Nikkel AL; Robb HM; Donnelly-Roberts DL; Prakash J; Swensen AM; Rubinstein ND; Krishnan S; McAllister FE; Haste NV; O'Brien JJ; Roy M; Ireland A; Frost JM; Shi L; Riedmaier S; Martin K; Dart MJ; Sidrauski C
    Elife; 2019 Jan; 8():. PubMed ID: 30624206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradoxical Sensitivity to an Integrated Stress Response Blocking Mutation in Vanishing White Matter Cells.
    Sekine Y; Zyryanova A; Crespillo-Casado A; Amin-Wetzel N; Harding HP; Ron D
    PLoS One; 2016; 11(11):e0166278. PubMed ID: 27812215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult mouse eIF2Bε Arg191His astrocytes display a normal integrated stress response in vitro.
    Wisse LE; Ter Braak TJ; van de Beek MC; van Berkel CGM; Wortel J; Heine VM; Proud CG; van der Knaap MS; Abbink TEM
    Sci Rep; 2018 Feb; 8(1):3773. PubMed ID: 29491431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo base editing of a pathogenic Eif2b5 variant improves vanishing white matter phenotypes in mice.
    Böck D; Revers IM; Bomhof ASJ; Hillen AEJ; Boeijink C; Kissling L; Egli S; Moreno-Mateos MA; van der Knaap MS; van Til NP; Schwank G
    Mol Ther; 2024 May; 32(5):1328-1343. PubMed ID: 38454603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanishing white matter disease expression of truncated EIF2B5 activates induced stress response.
    Keefe MD; Soderholm HE; Shih HY; Stevenson TJ; Glaittli KA; Bowles DM; Scholl E; Colby S; Merchant S; Hsu EW; Bonkowsky JL
    Elife; 2020 Dec; 9():. PubMed ID: 33300869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Three-dimensional Structure of eIF2B: A Clue to Understanding the Pathogenesis of CACH/VWM Disease].
    Kashiwagi K; Ito T; Yokoyama S
    Brain Nerve; 2017 Jan; 69(1):45-50. PubMed ID: 28126977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the genes encoding eukaryotic translation initiation factor 2B in Japanese patients with vanishing white matter disease.
    Shimada S; Shimojima K; Sangu N; Hoshino A; Hachiya Y; Ohto T; Hashi Y; Nishida K; Mitani M; Kinjo S; Tsurusaki Y; Matsumoto N; Morimoto M; Yamamoto T
    Brain Dev; 2015 Nov; 37(10):960-6. PubMed ID: 25843247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic dissection of vanishing white matter pathogenesis.
    Man JHK; Zarekiani P; Mosen P; de Kok M; Debets DO; Breur M; Altelaar M; van der Knaap MS; Bugiani M
    Cell Mol Life Sci; 2024 May; 81(1):234. PubMed ID: 38789799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of safety and early efficacy of AAV gene therapy in mouse models of vanishing white matter disease.
    Herstine JA; Chang PK; Chornyy S; Stevenson TJ; Sunshine AC; Nokhrina K; Rediger J; Wentz J; Vetter TA; Scholl E; Holaway C; Pyne NK; Bratasz A; Yeoh S; Flanigan KM; Bonkowsky JL; Bradbury AM
    Mol Ther; 2024 Jun; 32(6):1701-1720. PubMed ID: 38549375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
    Pan YX; Wu Y; Niu ZP; Jiang YW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism.
    Woody AL; Hsieh DT; McIver HK; Thomas LP; Rohena L
    Am J Med Genet A; 2015 Apr; 167A(4):826-30. PubMed ID: 25758335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant eIF2B leads to impaired mitochondrial oxidative phosphorylation in vanishing white matter disease.
    Raini G; Sharet R; Herrero M; Atzmon A; Shenoy A; Geiger T; Elroy-Stein O
    J Neurochem; 2017 Jun; 141(5):694-707. PubMed ID: 28306143
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.